دورية أكاديمية

A Comparison of Intranasal Corticosteroid, Leukotriene Receptor Antagonist, and Topical Antihistamine in Reducing Symptoms of Perennial Allergic Rhinitis as Assessed through the Rhinitis Severity Score

التفاصيل البيبلوغرافية
العنوان: A Comparison of Intranasal Corticosteroid, Leukotriene Receptor Antagonist, and Topical Antihistamine in Reducing Symptoms of Perennial Allergic Rhinitis as Assessed through the Rhinitis Severity Score
المؤلفون: Niti Sardana M.S., Carah Santos M.S., Erik Lehman M.A., Timothy Craig D.O.
المصدر: Allergy & Rhinology, Vol 1 (2010)
بيانات النشر: SAGE Publishing, 2010.
سنة النشر: 2010
المجموعة: LCC:Otorhinolaryngology
LCC:Immunologic diseases. Allergy
مصطلحات موضوعية: Otorhinolaryngology, RF1-547, Immunologic diseases. Allergy, RC581-607
الوصف: Rhinitis symptom complex consists of rhinorrhea, congestion, itchy mucosa, itchy eyes, and sneezing. Available medications vary in their benefit for each of these symptoms. It was the purpose of this article to compare symptom reduction with three different classes of medications. Montelukast, azelastine, and budesonide were compared to determine the effect on individual, as well as total, symptom scores using the Rhinitis Severity Score (RSS). All three medications were compared with placebo and showed efficacy in prior studies using Balaam's crossover design. The inclusion and exclusion criteria and all procedures were identical for all three studies. In analyzing the data from the RSS questionnaire, we used the procedure PROC MIXED in SAS specific for Balaam's crossover design (SAS Institute, Inc., Cary, NC). Although all three medications were effective compared with placebo, montelukast had the greatest effect of the three medications on reduction of ocular itching and throat and palate itching. Azelastine's effect was greater than budesonide and montelukast for reduction of rhinorrhea. Systemic medication, montelukast, as expected, provided better relief for symptoms distant from the nasal cavity, and the antihistamine, azelastine, reduced rhinorrhea, more than either montelukast or budesonide.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2152-6567
Relation: https://doaj.org/toc/2152-6567
DOI: 10.2500/aap.2010.31.3308
URL الوصول: https://doaj.org/article/a90e593bb5914d88b6bfd249b51f504e
رقم الأكسشن: edsdoj.90e593bb5914d88b6bfd249b51f504e
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:21526567
DOI:10.2500/aap.2010.31.3308